MedTrace Logo

Vonoprazan in Helicobacter Pylori Treatment an RCT

NCT04901663 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2021-08-18

No results posted yet for this study

Summary

RCT for comparison of Standard Triple therapy (Omeprazole+Amoxil+Clarithromycin) for H Pylori erradication with Vonoprazan+Amoxil dual therapy.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Omeprazole 20 MG Capsule; Amoxicillin 1000 MG; Clarithromycin 500 MG

Orally twice daily for 2 weeks

DRUG

Vonoprazan 20 MG; Amoxicillin 1000 MG

Orally twice daily for 2 weeks

Sponsors & Collaborators

  • Dow University of Health Sciences

    lead OTHER

Principal Investigators

  • Bader F Zuberi, FCPS · Dow University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2021-08-13
Completion
2021-08-16

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04901663 on ClinicalTrials.gov